Patents by Inventor Sidney A. Crow
Sidney A. Crow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11504418Abstract: Disclosed herein is an endotoxin-free asparaginase enzyme. Also disclosed are methods of using the disclosed enzyme to treat subjects with a disease treatable by depletion of asparagine. For example, the disclosed endotoxin-free asparaginase enzyme is useful in the treatment or the manufacture of a medicament for use in the treatment of acute lymphoblastic leukemia (ALL) in both adults and children, as well as other conditions where asparagine depletion is expected to have a useful effect.Type: GrantFiled: November 2, 2017Date of Patent: November 22, 2022Assignee: CROWPIERCE TECHNOLOGIES, LLCInventors: George E. Pierce, Sidney A. Crow
-
Publication number: 20220053761Abstract: Disclosed are purified proteins, cell lysates, cell-free extracts, and protein extracts comprising 1-hexene monooxygenase (1-HMO) and methods of their use for delaying plant development.Type: ApplicationFiled: August 19, 2021Publication date: February 24, 2022Inventors: Sidney Crow, JR., George Pierce
-
Patent number: 11246312Abstract: Disclosed herein are antimicrobial compositions that are substantially odorless. The antimicrobial compositions can comprise, for example, a first essential oil and a second essential oil, wherein the composition is substantially odorless. In some examples, the composition can further comprise a third essential oil. The compositions described herein can, for example, reduce the population of microbes, such as Staphylococcus aureus or Escherichia coli, by 5 log or more. Also disclosed herein are beverages and food products including the compositions disclosed herein. Also disclosed herein is milk including the compositions disclosed herein. Also disclosed herein are methods for treating or preventing a microbial infection in a subject, the methods comprising administering to the subject an effective amount of any of the compositions disclosed herein. Also disclosed herein are methods for combating bovine mastitis, the methods comprising applying any of the compositions disclosed herein to cow udders.Type: GrantFiled: January 5, 2018Date of Patent: February 15, 2022Assignee: CROWPIERCE TECHNOLOGIES, LLCInventors: George Pierce, Sidney Crow, Amber Keller
-
Publication number: 20200010503Abstract: Provided herein are methods of producing a heterologous polypeptide and compositions comprising same.Type: ApplicationFiled: September 5, 2018Publication date: January 9, 2020Inventors: George E. Pierce, Susan A. Burran, Trudy Ann Tucker, Shelby Jones-Dozier, Jennifer Hooker, Sidney A. Crow
-
Publication number: 20190343894Abstract: Disclosed herein are antimicrobial compositions that are substantially odorless. The antimicrobial compositions can comprise, for example, a first essential oil and a second essential oil, wherein the composition is substantially odorless. In some examples, the composition can further comprise a third essential oil. The compositions described herein can, for example, reduce the population of microbes, such as Staphylococcus aureus or Escherichia coli, by 5 log or more. Also disclosed herein are beverages and food products including the compositions disclosed herein. Also disclosed herein is milk including the compositions disclosed herein. Also disclosed herein are methods for treating or preventing a microbial infection in a subject, the methods comprising administering to the subject an effective amount of any of the compositions disclosed herein. Also disclosed herein are methods for combating bovine mastitis, the methods comprising applying any of the compositions disclosed herein to cow udders.Type: ApplicationFiled: January 5, 2018Publication date: November 14, 2019Inventors: George PIERCE, Sidney A. CROW, Amber KELLER
-
Publication number: 20190275121Abstract: Disclosed herein is an endotoxin-free asparaginase enzyme. Also disclosed are methods of using the disclosed enzyme to treat subjects with a disease treatable by depletion of asparagine. For example, the disclosed endotoxin-free asparaginase enzyme is useful in the treatment or the manufacture of a medicament for use in the treatment of acute lymphoblastic leukemia (ALL) in both adults and children, as well as other conditions where asparagine depletion is expected to have a useful effect.Type: ApplicationFiled: November 2, 2017Publication date: September 12, 2019Inventors: George E. Pierce, Sidney A. Crow
-
Patent number: 10300093Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth in or on a subject. The methods comprise exposing the subject to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to the subject in a quantity sufficient to inhibit or reduce fungal growth.Type: GrantFiled: June 10, 2015Date of Patent: May 28, 2019Assignee: Georgia State University Research Foundation, Inc.Inventors: George E. Pierce, Sidney A. Crow, Jr., Trudy Ann Tucker, Christopher T. Cornelison
-
Publication number: 20190133137Abstract: Provided are methods and compositions for inhibiting seed germination. The methods comprise exposing a seed to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to seed in a quantity sufficient to inhibit seed germination.Type: ApplicationFiled: June 6, 2017Publication date: May 9, 2019Inventors: George E. Pierce, Sidney A. Crow
-
Patent number: 10244765Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth. The methods comprise exposing a location to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to location in a quantity sufficient to inhibit or reduce fungal growth.Type: GrantFiled: May 21, 2018Date of Patent: April 2, 2019Assignee: Georgia State University Research Foundation, Inc.Inventors: George E. Pierce, Sidney Crow
-
Publication number: 20180332859Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth. The methods comprise exposing a location to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to location in a quantity sufficient to inhibit or reduce fungal growth.Type: ApplicationFiled: May 21, 2018Publication date: November 22, 2018Inventors: George E. Pierce, Sidney Crow
-
Patent number: 10004237Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth. The methods comprise exposing a location to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to location in a quantity sufficient to inhibit or reduce fungal growth.Type: GrantFiled: March 13, 2014Date of Patent: June 26, 2018Assignee: Georgia State University Research Foundation, Inc.Inventors: George E. Pierce, Sidney Crow
-
Publication number: 20170112882Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth in or on a subject. The methods comprise exposing the subject to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to the subject in a quantity sufficient to inhibit or reduce fungal growth.Type: ApplicationFiled: June 10, 2015Publication date: April 27, 2017Applicant: GEORGIA STATE UNIVERSITY AND RESEARCH FOUNDATION INC.Inventors: George E. Pierce, Sidney A. Crow, Jr., Trudy Ann Tucker, Christopher T. Cornelison
-
Publication number: 20170114383Abstract: Provided herein are methods of producing a heterologous polypeptide and compositions comprising same.Type: ApplicationFiled: January 6, 2017Publication date: April 27, 2017Inventors: George E. Pierce, Susan A. Burran, Trudy Ann Tucker, Shelby Jones-Dozier, Jennifer Hooker, Sidney A. Crow, JR.
-
Publication number: 20160021890Abstract: Provided are methods and compositions for inhibiting or reducing fungal growth. The methods comprise exposing a location to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to location in a quantity sufficient to inhibit or reduce fungal growth.Type: ApplicationFiled: March 13, 2014Publication date: January 28, 2016Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: George E. Pierce, Sidney Crow
-
Publication number: 20150056653Abstract: Provided herein are methods of producing a heterologous polypeptide and compositions comprising same.Type: ApplicationFiled: July 27, 2012Publication date: February 26, 2015Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.Inventors: George E. Pierce, Susan A. Burran, Trudy Ann Tucker, Shelby Jones-Dozier, Jennifer Hooker, Sidney A. Crow, JR.